Nelson DR - Search Results

1

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial.

Rodriguez-Torres M, Lawitz E, Kowdley KV, Nelson DR, Dejesus E, McHutchison JG, Cornpropst MT, Mader M, Albanis E, Jiang D, Hebner CM, Symonds WT, Berrey MM, Lalezari J. Rodriguez-Torres M, et al. Among authors: nelson dr. J Hepatol. 2013 Apr;58(4):663-8. doi: 10.1016/j.jhep.2012.11.018. Epub 2012 Nov 23. J Hepatol. 2013. PMID: 23183528 Clinical Trial.

2

Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

Gish RG, Arora S, Rajender Reddy K, Nelson DR, O'Brien C, Xu Y, Murphy B. Gish RG, et al. Among authors: nelson dr. J Hepatol. 2007 Jul;47(1):51-9. doi: 10.1016/j.jhep.2007.02.018. Epub 2007 Mar 12. J Hepatol. 2007. PMID: 17470380 Clinical Trial.

3

Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.

Patel K, Nelson DR, Rockey DC, Afdhal NH, Smith KM, Oh E, Hettinger K, Vallée M, Dev A, Smith-Riggs M, McHutchison JG. Patel K, et al. Among authors: nelson dr. Clin Gastroenterol Hepatol. 2008 Feb;6(2):242-7. doi: 10.1016/j.cgh.2007.11.009. Epub 2008 Jan 9. Clin Gastroenterol Hepatol. 2008. PMID: 18187364

4

Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin.

Fried MW, Jensen DM, Rodriguez-Torres M, Nyberg LM, Di Bisceglie AM, Morgan TR, Pockros PJ, Lin A, Cupelli L, Duff F, Wang K, Nelson DR. Fried MW, et al. Among authors: nelson dr. Hepatology. 2008 Oct;48(4):1033-43. doi: 10.1002/hep.22448. Hepatology. 2008. PMID: 18697207 Clinical Trial.

5

Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.

Nelson DR, Rustgi V, Balan V, Sulkowski MS, Davis GL, Muir AJ, Lambiase LR, Dickson RC, Weisner RH, Fiscella M, Cronin PW, Pulkstenis E, McHutchison JG, Subramanian GM. Nelson DR, et al. Clin Gastroenterol Hepatol. 2009 Feb;7(2):212-8. doi: 10.1016/j.cgh.2008.10.035. Epub 2008 Nov 7. Clin Gastroenterol Hepatol. 2009. PMID: 19061971 Clinical Trial.

6

Ribavirin: current role in the optimal clinical management of chronic hepatitis C.

Reddy KR, Nelson DR, Zeuzem S. Reddy KR, et al. Among authors: nelson dr. J Hepatol. 2009 Feb;50(2):402-11. doi: 10.1016/j.jhep.2008.11.006. Epub 2008 Dec 3. J Hepatol. 2009. PMID: 19091439 Free article. Review.

7

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.

Benhamou Y, Afdhal NH, Nelson DR, Shiffman ML, Halliman DG, Heise J, Chun E, Pockros PJ. Benhamou Y, et al. Among authors: nelson dr. Hepatology. 2009 Sep;50(3):717-26. doi: 10.1002/hep.23073. Hepatology. 2009. PMID: 19585653 Clinical Trial.

8

Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin.

Diago M, Shiffman ML, Bronowicki JP, Zeuzem S, Rodriguez-Torres M, Pappas SC, Tietz A, Nelson DR. Diago M, et al. Among authors: nelson dr. Hepatology. 2010 Jun;51(6):1897-903. doi: 10.1002/hep.23531. Hepatology. 2010. PMID: 20196118 Clinical Trial.

9

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team. Nelson DR, et al. Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1. Gastroenterology. 2010. PMID: 20600017 Free PMC article. Clinical Trial.

10

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.

Bzowej N, Nelson DR, Terrault NA, Everson GT, Teng LL, Prabhakar A, Charlton MR; PHOENIX Study Group. Bzowej N, et al. Among authors: nelson dr. Liver Transpl. 2011 May;17(5):528-38. doi: 10.1002/lt.22271. Liver Transpl. 2011. PMID: 21506241 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

937 results

Search Page

Filters